Mobile App

WHERE THE BRIGHTEST MINDS in health and IT meet.

Thomas Brown

MD, MBA
Executive Director
Swedish Cancer Institute (SCI)
Thomas Brown, MD, MBA serves as Executive Director of the Swedish Cancer Institute (SCI) overseeing all clinical, research, business, and administrative operations for SCI. Dr. Brown is responsible for overseeing the Institute's Swedish-based operations and programs throughout the five hospital campuses, along with network development; leading SCI's vision in Personalized Medicine initiative, strategy, planning, advocacy and execution work; furthering relationship development with the Providence Health & Services network; organizing and leading efforts to reposition SCI for health-care reform; overseeing the Institute's clinical research efforts and advanced technology initiatives; as well as championing SCI's fund-raising efforts. Dr. Brown also serves as the Co-Chair of the Cancer Leadership Advisory Council Executive Committee for Providence Health & Services (PHS). Prior to coming to Swedish, Dr. Brown served as professor of medicine and chief operating officer of the University of Arizona Cancer Center. He served on the faculty of the University of Texas MD Anderson Cancer Center for a decade, to include: as a professor in gastrointestinal oncology; deputy head and head ad interim, of the Division of Cancer Medicine; and vice president for extramural programs and international business. While on the faculty at Duke University, as associate professor of medicine, he led development of the multi-disciplinary GI cancer program and a regional, community-based clinical trial consortium. He holds a Bachelor of Arts degree from The Johns Hopkins University, and a MBA from Rice University. A graduate of the Medical College of Virginia, Dr. Brown completed an internal medicine residency at the University of Florida and a fellowship in medical oncology at The Johns Hopkins University School of Medicine. Dr. Brown's clinical practice and research focus has been on therapeutic development in gastrointestinal malignancies.

WHERE THE BRIGHTEST MINDS

in health and IT meet.

JOIN US